Bayer reported €3.89B in Cost of Sales for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Akzo Nobel AKZA:NA 1.48B 6M
Alcon AG ALC:SW 908M 18M
Amarin AMRN:US $ 30.21M 1.94M
Arkema AKE:FP € 1826M 14M
AstraZeneca AZN:LN 3824M 1631M
BASF BAS:GR € 14762M 90M
Bayer BAYN:GR € 3887M 659M
Corteva Inc CTVA:US $ 1.56B 1.45B
Covestro 1COV:GR 3.07B 253M
Fresenius FRE:GR € 6801M 173M
Fresenius Medical Care FME:GR € 3174M 137.82M
Givaudan GIVN:VX 1.89B 92M
GlaxoSmithKline GSK:LN 2822M 303M
GRIFOLS GRF:SM € 771.1M 119.7M
H. Lundbeck A/S LUN:DC 851M 0
Hikma Pharmaceutical HIK:LN 600M 2M
Johnson Matthey JMAT:LN 8.04B 29M
Linde LIN:GR 4.37B 174M
Lonza Group LONN:SW 1.5B 690M
Merck MRK:GR € 1859M 46M
Novartis NOVN:VX SF 3848M 94M
Nutrien Ltd NTR:CN C$ 3.86B 3.02B
Philips PHIA:NA € 2182M 259M
Ppg Industries PPG:US $ 2733M 104M
SAP SAP:GR € 1903M 11M
Solvay SOLB:BB € 2116M 175M
Umicore UMI:BB 11.76B 1.61B